In2Care® is a company in the Netherlands that developed the In2Care® Mosquito Trap and In2Care® Eave Tubes to safely and effectively reduce mosquito populations. These US-EPA registered products aim to combat insects that transmit harmful diseases such as Malaria, Dengue, West Nile Virus, Chikungunya, and Zika. The In2Care® Company prides itself on its extensive research, testing, and validation of its products aiming to bring customers a multi-impact tool to fight mosquitoes.
The In2Care® stations are filled with water and an odorous tablet that attracts the female mosquito to lay her eggs. When a female enters the trap, she lands on a floater cover with a gauze strip. The gauze is coated with 2 biological agents: a larvicide (Pyriproxyfen), and a fungal spore (Beauveria bassiana). While the female mosquito rests on the gauze, the active ingredients are transferred to the female.
The female mosquito then flies out carrying the bioactive which contaminates the surrounding sites with the larvicide. This larvicide is effective because it kills the larvae in the traps and in surrounding breeding sites. After a few hours, the fungal spore carried by the female germinates, spreads the larvicide through her system, and kills the adult mosquito.
